Menu
GeneBe

IPO11

importin 11, the group of Importins

Basic information

Region (hg38): 5:62403971-62628582

Links

ENSG00000086200NCBI:51194OMIM:610889HGNC:20628Uniprot:Q9UI26AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the IPO11 gene.

  • Inborn genetic diseases (52 variants)
  • not provided (9 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the IPO11 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
6
clinvar
6
missense
25
clinvar
2
clinvar
1
clinvar
28
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
24
clinvar
1
clinvar
1
clinvar
26
Total 0 0 49 3 8

Variants in IPO11

This is a list of pathogenic ClinVar variants found in the IPO11 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-62435869-A-AAATACAAAAATTAGCTGGGCTTGGTGGTGTGCGCCTGTAATCCCAAATACTGGGGAGGCTGAGGCAGGAGAATCGCTTGAACCCGGGAGGTGGAGTGAGTTGAGATTGTGCTGTTGCACTCGAGCCTGGGTGACAGAGTGAGACTCTGTCTCAAAAAATAAATCAAAATCAAATCAAATCTTAATCCAACTCTATCAGTAACTTGGTATTTTTCAGATTCTAGTTATTAGGCCCTTTTTAAGATGGTACAATGAAATTTTTGTGTTTTTGATTAGCCCTGCTTTACTTACATAGGTTTTGAAATGGTTGATTTTCCCTAAAAGGTAATCTAGGTCAGATTTCTTGTTGAATCAACATTTGGAATCTTGCCATTTCACTGCAATTTAATTGTAATTATTTTAACAAAGGAATTCATTTGCTTTGGCTATATTCTTTATAGGCTAATAACTTTCAGACTTTTACTGTCTGGAACATTCTTCGGTCACAGAGATAGCCACTGTCACTAAGCTGTATCAATACAGTACAACGCTATTCCCTGTCACCCCTGCACTGAGAACTTCGACTTATTTTCTGTCAATATTTTTAGCTTTCAATTTTAATCCTTATATTTTGTACGTGTATATTGTGAATAACTATACATACTTGCTAAGTATAGAATTGTATATACAATTTTGGGGGTGATTAGAAACAGAATCCCGGAGAATTCAACAAAATCAAGAAATTGTGTGTTTGTTGAATGGCTTCAGCTACATGGTATAGGATTAGATGACCCAGCCCTTAAGATCCTTTCTGACTTAGGTTTTAGATTTTTGTTTAATAGGTCAGTTTGGCTTTTTTCCCCATAGCATTTCATTTTGTATGTTTCTTAAAATGATTTGGAGATGCACCATTGGTGGCACGTAAGATGATGTTGGAGAGTACTTTACTAACAAGTCAAAGCAATTCTTTTGCAGTTTTCTTTTCTTCCTTCTGATTTTGTCAAGGATAAAGTTAGGTGTTACTTACTGTATGGTTTAATACTTTTATAACACTTATTAATCTCCTTTTTAAAACGAAGACAGAAGACATTATGCTTAGTCTTGGGCACGTAATGGTACTTACTCAGAATTTAGAAACTTTGAAGTTTGTGTGTGTATCTCCCCTCCCTCAATTTATTATCTTCTATTTATGGAACAATGAAAGAGAGTTTCCTTTAGGAATAAATTGATTTAAGCAAAAATAATTTGATTATGAATTTTAAGGATGAGTATGGGGTATACTTAGAAAAGATAGAAAGGCAGAACATGAAGGATTAGATGAATGGGAGTAATTCAGAACATGAAAGCTTTTTGTCTCCATTTATTTTACTGTTAATTTTTTATTACTTGTAATACATATTCAAGTATGTTAACTTATCATTGCCAGGTTTCCATGGATCTCAATAGTGCCAGCACTGTTGTTCTTCAGGTGTTAACACAGGCCACCAGTCAGGATACTGCTGTGTTAAAACCAGCTGAGGAGCAGTTGAAGCAGTGGGAGACACAGCCAGGTTTCTATTCAGTGTTGCTGGTAAGTTGTTCTAAAATTGTTTGCTTTTCTTTTTAATAAAATGAGACAACATTAATTTGTTTTAAAACCCTAGTTTTATTGGTAGTTTAGTGAAATAGATTCAGATGTTTGGCTGCTGATGCCTTTGCCATTATCTTATTACTTTATGACTTCTTAAGGGTGTTAAATAAATATTTATTGATAAATATAAAAATAAGCTAGGTATATGTAGCATCTGCTCAGAAGGCAAAACTGTGATGATTTTCAGTTTTAGTACGTTAAAAGTGTCTACTATCAGGACTCTAGGTAGCACTCTTTCATATTTTGTCTTTATCCCTACCCCAGGTAATTTATGTTGTCATAGTTGTTCAGGTCTCCACATTGCAGCATCAATGTCAGGTGTACCGTGTATTTCACTTTAAAATGTTTTCTTTTCTCATCTAAAAATTTCATTCTCTTGACACAGCTGATGTTTTCTTGGATATAATGGGAAATGGTATAATTAATTAACAATATGTGCTTTAAATTAACCTTTATTGGAGTTCAAAGTTTTTGACTAATTAATCAAAATTATTTTCTCAATGCCAGAATGAAAGAAGTCTTTTTGTGTTGAACACTTTCCTTATACTTTTCTTCTGAGAAATTGAGAACTCTGATTAGTGTTTGAGGTTTAGCTTCTGGTCAGGGCAACAAAGCTCCCCGTTGGGTTAAAAACTGACTCAGTATTTGTGACCAGGTCATAGAATCAGAGCAAAATTGTTTATTATATCTTGCAAAATAAAATAAATGATAGCAGTTGTCATATATATTTTAACTTGTTGGCTAAAAAAGTTTGAGTTGTTTGTTAAATTGAAGAAGATATTGTTCATGACAGTAAGGGAAATTGTTTAAAGTCAGACTTGTTATCCTGAATATAACAAAAAAGATGGCTGTTTGGCTCAGTAACAGAATCGTAAAAAAAAAAAGATTGATTTTAAAAGATACTAAAGAAAACATCTTATTCTTTATGTAATCTTAGCATCATGTTTGTAAATTTTAGGCATAGTATAAATCTTTAGAAAATCTCTTGAGTAGGGCCGGGTGCAGTGGCTCACTCCTGTAATCCCAGCACTTTGGGAGGCCAAGGCGGGTGGATCACCTGAGGTCAGGAGTTTGAGACCAGCCTGACTGACATGCTGAAACCCCATCTCTACTGAAAATACAAAATTAGCCAGGTGTGGTGGCGCACGCCTGTAGTCGCAGCTATTCATGAGGCTGAGGCAGGAGAATCGCTTGAACTCAGGAGGCGGAGGTTGCAGTGAGCTGAGATCGTGCCATTGTACTCCAGTCTGGGCAACAAGAACGAAACTCCATCTCAAAAAAAAAAGGGGGGGAGCAGCGGGGCCAGGTGTGGTGGCTTATGCCTGTCATCCCAGCACTTTGGGAGGCCAAGGCGGGCGAATCACGTGACCAGGAGATTGAGACCATCCTGACTAACACGGTGAAATCCCGTCTCTACTAAAAATACAAAAAATTAGCCAGGCATGGTGGCGGGCGCCTGTAGTCCCAGCTACTTGGGAGGCTGAAGCAGGAGAATGGTGTGAACCCAGGAAGCAGAGCTTGCAGTGAGTGGAGATTGCACCACTGCATTCCAACCTGGGCGACAGAGTAAGACTCCATCTCAAAAAAAAAAAAAAAAAAATCTCTTGAGTATCTTTACTCTCCTTACGCTTATTTAAATG Congenital hydrocephalus Uncertain significance (Jul 05, 2018)684698
5-62437290-A-G not specified Uncertain significance (Feb 16, 2023)2485531
5-62442993-C-T not specified Uncertain significance (Jan 04, 2024)3110298
5-62451730-A-G not specified Uncertain significance (Dec 09, 2023)3110303
5-62451753-C-G Benign (Jun 01, 2018)768002
5-62451853-A-G not specified Uncertain significance (Feb 27, 2023)2489719
5-62451933-T-C Likely benign (Jun 01, 2018)716113
5-62467186-C-T not specified Uncertain significance (Apr 07, 2022)2282077
5-62470285-C-G not specified Uncertain significance (Dec 30, 2023)3110305
5-62470318-C-T Benign (Feb 08, 2018)769651
5-62474441-G-A not specified Uncertain significance (Dec 22, 2023)3110306
5-62474443-C-T Benign (Jun 01, 2018)716114
5-62474450-A-G not specified Uncertain significance (Feb 15, 2023)3110307
5-62476686-G-A not specified Uncertain significance (Dec 30, 2023)3110308
5-62476703-A-G Benign (May 31, 2018)781996
5-62476706-G-A not specified Uncertain significance (Jun 27, 2022)2388560
5-62483266-G-A not specified Uncertain significance (Dec 05, 2022)2378399
5-62483273-A-C not specified Uncertain significance (May 11, 2022)2288523
5-62484018-C-A not specified Uncertain significance (Dec 02, 2021)2241829
5-62484076-C-T not specified Uncertain significance (Jun 09, 2022)2221275
5-62487777-A-G not specified Uncertain significance (Feb 22, 2023)2470105
5-62487811-A-G not specified Uncertain significance (Jun 06, 2023)2557536
5-62487831-G-T not specified Uncertain significance (Oct 13, 2023)3110295
5-62504670-C-T not specified Uncertain significance (Jul 05, 2023)2603248
5-62504871-T-C Benign (Jun 01, 2018)716115

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
IPO11protein_codingprotein_codingENST00000409296 30224611
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.001660.9981257230241257470.0000954
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.374195060.8280.00002436650
Missense in Polyphen93155.40.598472116
Synonymous0.5311651740.9490.000008301861
Loss of Function5.311863.80.2820.00000340774

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002330.000233
Ashkenazi Jewish0.000.00
East Asian0.0001140.000109
Finnish0.000.00
European (Non-Finnish)0.0001000.0000967
Middle Eastern0.0001140.000109
South Asian0.0001070.0000980
Other0.0003300.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Functions in nuclear protein import as nuclear transport receptor. Serves as receptor for nuclear localization signals (NLS) in cargo substrates. Is thought to mediate docking of the importin/substrate complex to the nuclear pore complex (NPC) through binding to nucleoporin and the complex is subsequently translocated through the pore by an energy requiring, Ran- dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to the importin, the importin/substrate complex dissociates and importin is re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus (By similarity). Mediates the nuclear import of UBE2E3, and of RPL12 (By similarity). {ECO:0000250, ECO:0000269|PubMed:11032817}.;

Recessive Scores

pRec
0.111

Intolerance Scores

loftool
0.773
rvis_EVS
-0.53
rvis_percentile_EVS
20.86

Haploinsufficiency Scores

pHI
0.697
hipred
Y
hipred_score
0.704
ghis
0.600

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.864

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ipo11
Phenotype
homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
protein import into nucleus;ribosomal protein import into nucleus
Cellular component
fibrillar center;nucleus;nuclear envelope;cytosol
Molecular function
protein binding;Ran GTPase binding;protein transporter activity